Stockscreener 앱 받기
6.37
2.45%
-0.16
시간 외 거래:
6.53
0.16
+2.51%
Bioharvest Sciences Inc 주식(BHST)의 최신 뉴스
Craig-Hallum Recommends BioHarvest Sciences (BHST) with Strong Buy Rating | BHST Stock News - GuruFocus
BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time | BHST Stock News - GuruFocus
BioHarvest Sciences to Announce Q1 2025 Financial Results - TipRanks
BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time - Newsfile
BioHarvest Sciences Inc. (BHST) Soars 5.2%: Is Further Upside Left in the Stock? - MSN
Analysts Set Expectations for BHST Q1 Earnings - Defense World
Research Analysts Set Expectations for BHST Q2 Earnings - The AM Reporter
What is HC Wainwright’s Estimate for BHST Q2 Earnings? - Defense World
BioHarvest Sciences’ (BHST) Buy Rating Reaffirmed at HC Wainwright - Defense World
H.C. Wainwright maintains BioHarvest stock Buy rating, $14 target - Investing.com Australia
H.C. Wainwright maintains BioHarvest stock Buy rating, $14 target By Investing.com - Investing.com Canada
Here's Why BioHarvest Sciences (NASDAQ:BHST) Can Afford Some Debt - simplywall.st
Q1 Earnings Forecast for BHST Issued By Diamond Equity - Defense World
BioHarvest Sciences Reports Strong Revenue Growth and Strategic Expansion - TipRanks
BioHarvest Sciences Reports Strong Growth Amid Challenges - TipRanks
BioHarvest CEO talks Nasdaq uplisting, profit targetsICYMI - Proactive financial news
BioHarvest Sciences Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance
BioHarvest shares rise after Q4 results show strong demand for VINIA products - Proactive financial news
Small cap wrap: Ideal Power, Voyageur Pharmaceuticals, North Bay Resources, Trust Stamp... - Proactive Investors
BioHarvest Sciences reports record-breaking 2024 revenue and expansion milestones - Proactive financial news
BioHarvest Sciences Inc (BHST) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo
BioHarvest Sciences Inc (BHST) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
BioHarvest Sciences Inc. (BHST) Reports Q4 Loss, Lags Revenue Estimates - MSN
BioHarvest Sciences Reports Strong Financial Growth and Strategic Partnership - TipRanks
BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results - Newsfile
Contrasting CureVac (NASDAQ:CVAC) & BioHarvest Sciences (NASDAQ:BHST) - The AM Reporter
BioHarvest Sciences (BHST) to Release Earnings on Monday - Defense World
Ilan Sobel, CEO of BioHarvest Sciences - iHeart
Strength Seen in BioHarvest Sciences Inc. (BHST): Can Its 12.7% Jump Turn into More Strength? - Nasdaq
BioHarvest Sciences to Announce Q4 and Full Year 2024 Financial Results - TipRanks
BioHarvest Sciences to Host Fourth Quarter and Full Year 2024 Earnings Call on March 31 at 4:30 p.m. Eastern Time - Newsfile
BioHarvest Announces Appointment of Sharon Malka to Board of Directors - Newsfile
BIOHARVEST SCIENCES INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com
BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025 - Newsfile
BioHarvest Sciences achieves breakthrough in Liver health with Olive Cell compound - Proactive Investors USA
BioHarvest’s Olive Cell Compound Shows Promise in Tackling Liver Fat Accumulation - TipRanks
BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells - Newsfile
EXCLUSIVE: Botanical Synthesis Tech-Focused BioHarvest's First Synthetic Olive Cells Shows Reduced Fat Accumulation in Liver Cells - Benzinga
BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD - Newsfile
BioHarvest Sciences Inc. (NASDAQ:BHST) Not Flying Under The Radar - Simply Wall St
BioHarvest Sciences Inc.'s (NASDAQ:BHST) Shift From Loss To Profit - Yahoo Finance
BioHarvest Sciences surpasses 50 million dollars in VINIA sales, plans major production expansion - Proactive financial news
0.62%
1.39%
자본화:
|
볼륨(24시간):